Pharma Journalist -

SMi reports: An exclusive interview with Dalma Sugár, Global Medical Affairs Director, Reckitt Benckiser just ahead of SMi’s 19th Annual Pain Therapeutics Conference, taking place this…
Read More...

Vertex Pharmaceuticals Incorporated announced that treatment with the triple combination of the next-generation corrector VX-445, tezacaftor and ivacaftor resulted in statistically…
Read More...

NovaGo Therapeutics AG, a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, has closed a Series A financing round of CHF 10…
Read More...

Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules derived from human kidney adult stem cells in microfluidic chips.…
Read More...

Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for LORVIQUA (lorlatinib, approved…
Read More...

Novartis announced new data in 441 Chinese patients with moderate to severe plaque psoriasis from a Phase III study investigating the efficacy and safety of Cosentyx (secukinumab). The…
Read More...

Pacira Pharmaceuticals and MyoScience announced the signing of a definitive agreement for the acquisition of MyoScience by Pacira. MyoScience currently markets the ioveraº system, a…
Read More...

ReForm Biologics announced a collaboration with Astellas Pharma Inc. to reduce the viscosity of an Astellas clinical-stage biological pipeline program. Reform’s technology platform…
Read More...

Bayer has submitted an application for marketing authorization to the Ministry of Health, Labor and Welfare (MHLW) in Japan for darolutamide for the treatment of patients with…
Read More...

AnTolRx announced that Pfizer Inc. has exercised the option granted under a June 2016 agreement to license an immune tolerance therapy from AnTolRx's Type 1 diabetes research program.…
Read More...